Palbociclib Drops 93% to ₹2,720. Roche’s ₹123,506 Vial Doesn’t Budge
On November 9, a 21-capsule pack of palbociclib from RPG Life Sciences drops from ₹40,421…
Author: admin
Baxter Warning Letter Ends a $50M Cephalosporin Line With 60% Margins
Baxter International is shutting down a cephalosporin business that, by its own numbers, brings in…
Sugammadex Generics Wipe $353M Off Merck’s Bridion in One Quarter
Merck & Co., Inc. sold $497 million of Bridion (sugammadex) in the second quarter of…
The $245 Discount: Medicare Pays Up to 17× India’s Price for the Same Weight-Loss Molecule – and Calls It a Bargain
700,000 seniors, one flat copay, one net price agreed behind closed doors. Medicare’s GLP-1 Bridge…
The Annex III Club: Why September 29 Is the Real Deadline in Pharma’s Tariff War
Seventeen companies were named first when Washington imposed a 100% tariff on patented drugs and…
Antibiotic OPEC: The Shadow Cartels Monetizing the Ruins of the Strait of Hormuz
In the last fourteen days, the cost of keeping a feverish child stable in a…
The 21% Correction: Why Public Markets Are No Longer Buying Biotech Platforms Without Clinical Anchors
The biotech markets of early 2026 have become a theater of the extreme, where the…
Stop Searching, Start Connecting: Your Global API & FDF Hub
If you’ve been in the pharma business for a while, you know that finding a…
Checkbook Darwinism: Why Merck and Roche Are Paying ‘Panic Premiums’ to Avert Extinction
The pharmaceutical sector has officially transitioned from cautious capital preservation to a state of aggressive,…
Regulatory Shock Trades: How FDA Letters Move Billions Before Lunch
CRL Regulatory Shock Trades: How FDA Letters Move Billions Before Lunch No fireworks. A 7:12…